Martinez-Usatorre et al. applied a combined triple blockade targeting VEGF-A by B20 antibody, ANG-2 BI-836880 and PD-1 in an autochthonous NSCLC mouse model driven by mutated KRAS and TP53. Here, TP53 is linked to non-small cell lung carcinoma.